Search details
1.
Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses.
Cell
; 162(5): 974-86, 2015 Aug 27.
Article
in English
| MEDLINE | ID: mdl-26317466
2.
Integrative multi-omics analyses to identify the genetic and functional mechanisms underlying ovarian cancer risk regions.
Am J Hum Genet
; 2024 May 07.
Article
in English
| MEDLINE | ID: mdl-38723632
3.
Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses.
Cell
; 169(2): 361, 2017 04 06.
Article
in English
| MEDLINE | ID: mdl-28388418
4.
Genetic insights into biological mechanisms governing human ovarian ageing.
Nature
; 596(7872): 393-397, 2021 08.
Article
in English
| MEDLINE | ID: mdl-34349265
5.
Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses.
Cell
; 164(5): 1073, 2016 Feb 25.
Article
in English
| MEDLINE | ID: mdl-27064190
6.
Genome-wide association study and functional follow-up identify 14q12 as a candidate risk locus for cervical cancer.
Hum Mol Genet
; 31(15): 2483-2497, 2022 08 17.
Article
in English
| MEDLINE | ID: mdl-35157032
7.
Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element.
Am J Hum Genet
; 108(7): 1190-1203, 2021 07 01.
Article
in English
| MEDLINE | ID: mdl-34146516
8.
Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women.
N Engl J Med
; 384(5): 428-439, 2021 02 04.
Article
in English
| MEDLINE | ID: mdl-33471991
9.
Primary results of the AGO-Zervix-1 Study: A prospective, randomized phase III study to compare the effects of paclitaxel and topotecan with those of cisplatin and topotecan in the treatment of patients with recurrent and persistent cervical cancer.
Gynecol Oncol
; 183: 25-32, 2024 Apr.
Article
in English
| MEDLINE | ID: mdl-38490057
10.
PD-L1 Expression and Silva Invasion Pattern in Villoglandular Adenocarcinoma of the Uterine Cervix.
Int J Gynecol Pathol
; 2024 Jan 31.
Article
in English
| MEDLINE | ID: mdl-38293999
11.
Effects of prenatal alcohol exposition on cognitive outcomes in childhood and youth: a longitudinal analysis based on meconium ethyl glucuronide.
Eur Arch Psychiatry Clin Neurosci
; 274(2): 343-352, 2024 Mar.
Article
in English
| MEDLINE | ID: mdl-37532863
12.
Survival and hormone production of isolated mouse follicles in three-dimensional artificial scaffolds after stimulation with bpV(HOpic).
Arch Gynecol Obstet
; 309(5): 2127-2136, 2024 May.
Article
in English
| MEDLINE | ID: mdl-38472502
13.
Correlation of RANK and RANKL with mammographic density in primary breast cancer patients.
Arch Gynecol Obstet
; 2024 Jun 05.
Article
in English
| MEDLINE | ID: mdl-38836929
14.
A genome-wide gene-environment interaction study of breast cancer risk for women of European ancestry.
Breast Cancer Res
; 25(1): 93, 2023 08 09.
Article
in English
| MEDLINE | ID: mdl-37559094
15.
Ex Vivo Chromosomal Radiosensitivity Testing in Patients with Pathological Germline Variants in Breast Cancer High-Susceptibility Genes BReast CAncer 1 and BReast CAncer 2.
Curr Issues Mol Biol
; 45(8): 6618-6633, 2023 Aug 10.
Article
in English
| MEDLINE | ID: mdl-37623237
16.
CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study.
Cancer
; 129(5): 697-713, 2023 03 01.
Article
in English
| MEDLINE | ID: mdl-36572991
17.
Increased FOXJ1 protein expression is associated with improved overall survival in high-grade serous ovarian carcinoma: an Ovarian Tumor Tissue Analysis Consortium Study.
Br J Cancer
; 128(1): 137-147, 2023 01.
Article
in English
| MEDLINE | ID: mdl-36323878
18.
Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk.
Am J Hum Genet
; 107(5): 837-848, 2020 11 05.
Article
in English
| MEDLINE | ID: mdl-33022221
19.
Evaluating the Effectiveness of Mobile Health in Breast Cancer Care: A Systematic Review.
Oncologist
; 28(10): e847-e858, 2023 10 03.
Article
in English
| MEDLINE | ID: mdl-37536278
20.
Return of individual genomic research results within the PRAEGNANT multicenter registry study.
Breast Cancer Res Treat
; 197(2): 355-368, 2023 Jan.
Article
in English
| MEDLINE | ID: mdl-36409394